Stricter approval process reduces prescribing of anti-seizure drug that can cause birth defects

The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been effective at reducing the number of prescriptions issued for the drug, according to new research.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup